[Thrombolysis in cerebral ischemia. An overview]

Nervenarzt. 2001 Aug;72(8):590-9. doi: 10.1007/s001150170058.
[Article in German]

Abstract

Thrombolytic therapy for acute ischemic stroke within the 3-h time window has been approved. In the US, where FDA approval has existed for about 4 years, less than 2% of stroke patients presently receive thrombolytic therapy. This review illustrates all completed trials of intravenous and intra-arterial thrombolytic therapy for carotid artery and vertebrobasilar artery stroke and includes recommendations for therapy, diagnostic procedures and their effect on patient selection, meta-analyses, phase IV trials, and cost efficacy analyses.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cerebral Infarction / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Thrombolytic Therapy*
  • Treatment Outcome